Chantal Csajka

6.7k total citations
165 papers, 4.4k citations indexed

About

Chantal Csajka is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Chantal Csajka has authored 165 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 35 papers in Pediatrics, Perinatology and Child Health and 24 papers in Oncology. Recurrent topics in Chantal Csajka's work include HIV/AIDS drug development and treatment (29 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Pharmacogenetics and Drug Metabolism (19 papers). Chantal Csajka is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Pharmacogenetics and Drug Metabolism (19 papers). Chantal Csajka collaborates with scholars based in Switzerland, United States and France. Chantal Csajka's co-authors include Thierry Buclin, Laurent A. Décosterd, Nicolas Widmer, Monia Guidi, Serge Leyvraz, Amalio Telenti, Jérôme Biollaz, Chin B. Eap, Davide Verotta and Ferdy J. Lejeune and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Chantal Csajka

158 papers receiving 4.3k citations

Peers

Countries citing papers authored by Chantal Csajka

Since Specialization

Citations

This map shows the geographic impact of Chantal Csajka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Csajka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Csajka more than expected).

Fields of papers citing papers by Chantal Csajka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Csajka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Csajka. The network helps show where Chantal Csajka may publish in the future.

Co-authorship network of co-authors of Chantal Csajka

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Csajka. A scholar is included among the top collaborators of Chantal Csajka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Csajka. Chantal Csajka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quality assessment of Andrographis paniculata products reveals significant labelling inaccuracies and contaminations 2025 ·Swiss Medical Weekly ·(unknown), (unknown), Robin Huber, Chantal Csajka, Clara Podmore, Jean‐Luc Wolfender, (unknown), Pierre‐Yves Rodondi	0
2	Natural Language Processing and ICD-10 Coding for Detecting Bleeding Events in Discharge Summaries: Comparative Cross-Sectional Study 2025 ·JMIR Medical Informatics ·(unknown), (unknown), (unknown), E Bertrand, (unknown), Marie‐Annick Le Pogam, Chantal Csajka	0
3	A Systematic Review and Classification of the Effects of P-glycoprotein Inhibitors and Inducers in Humans, Using Digoxin, Fexofenadine, and Dabigatran as Probe Drugs 2025 ·Clinical Pharmacokinetics ·(unknown), Chantal Csajka	1
4	Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation 2024 ·JMIR Research Protocols ·Yann Thoma, (unknown), (unknown), (unknown), (unknown), Chantal Csajka, Monia Guidi, Stellah Mpagama	2
5	Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Perrine Courlet, Daniel Abler, Monia Guidi, Pascal Girard, Federico Amato, Naïk Vietti Violi, (unknown), (unknown), Alexandre Wicky, Sofiya Latifyan, (unknown), Mario Jreige, Clarisse Dromain, Chantal Csajka, John O. Prior, Karthik Venkatakrishnan, Olivier Michielin, Michel A. Cuendet, Nadia Terranova	7
6	Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project 2023 ·Frontiers in Psychiatry ·(unknown), (unknown), Chin B. Eap, Céline J. Fischer Fumeaux, Myriam Bickle Graz, Mathilde Morisod Harari, (unknown), Peggy Gandia, Karel Allegaert, Hedvig Nordeng, Jean‐Michel Hascoët, Olivier Claris, Manuella Epiney, Chantal Csajka, Monia Guidi, Ema Ferreira, Alice Panchaud	1
7	Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT) 2023 ·International Journal of Clinical Pharmacy ·(unknown), (unknown), (unknown), (unknown), (unknown), Marco Cattaneo, Patrick E. Beeler, Chantal Csajka, Monika Lutters	5
8	From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure 2023 ·Pharmaceutics ·Sylvain Goutelle, Monia Guidi, Verena Gotta, Chantal Csajka, Thierry Buclin, Nicolas Widmer	4
9	Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children 2022 ·Pharmaceutics ·Sylvain Goutelle, Yann Thoma, (unknown), (unknown), Thierry Buclin, Monia Guidi, Chantal Csajka	6
10	Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations 2022 ·European Respiratory Review ·(unknown), Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean‐François Brunet, Christophe von Garnier, Grégory Resch, Benoît Guéry	32
11	Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients – A cohort study comparing 19 anticholinergic burden scales 2022 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Patrick E. Beeler, Chantal Csajka, Monika Lutters	8
12	Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer 2022 ·Pharmaceutics ·Perrine Courlet, (unknown), (unknown), Athina Stravodimou, (unknown), Haïthem Chtioui, Isabella Locatelli, Laurent A. Décosterd, (unknown), Benoı̂t Blanchet, Jérôme Alexandre, Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka	6
13	Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP) 2022 ·British Journal of Clinical Pharmacology ·(unknown), Cédric Bovet, Regula Theurillat, Laurent A. Décosterd, Carlo R. Largiadèr, Jean‐Christophe Prost, Chantal Csajka, Daniela Bärtschi, Matthias Gückenberger, Roger von Moos, Sara Bastian, Markus Joerger, Ulrich Jaehde	1
14	Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration 2021 ·European Journal of Clinical Pharmacology ·Marta Ulldemolins, (unknown), Mireia Llauradó‐Serra, Chantal Csajka, Alejandro Rodríguez, Joan R. Badia, Ignacio Martín‐Loeches, Dolors Soy	8
15	Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs 2021 ·European Journal of Clinical Pharmacology ·Perrine Courlet, Monia Guidi, (unknown), Matthias Cavassini, Marcel Stoeckle, Thierry Buclin, Catia Marzolini, Laurent A. Décosterd, Chantal Csajka	6
16	Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review 2020 ·European Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Chantal Csajka, Monika Lutters	63
17	Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV 2020 ·Clinical Pharmacokinetics ·(unknown), Perrine Courlet, Laurent A. Décosterd, (unknown), Matthias Cavassini, Felix Stader, Marcel Stoeckle, Thierry Buclin, Catia Marzolini, Chantal Csajka, Monia Guidi	8
18	Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. 2017 ·Experimental and Clinical Psychopharmacology ·(unknown), Maria Dobrinas, Mehdi Gholam‐Rezaee, Rubin Lubomirov, Jacques Cornuz, Chantal Csajka, Chin B. Eap	12
19	Clinical pharmacokinetics of imatinib and its therapeutic relevance 2013 ·IRIS ·Nicolas Widmer, Verena Gotta, Amina Haouala, J.F. Blanc, Margaret von Mehren, Michel A. Duchosal, Serge Leyvraz, Chantal Csajka, Laurent A. Décosterd, Thierry Buclin	2
20	Docteur, puis-je boire de l'alcool avec mes antibiotiques ? 1996 ·IRIS ·(unknown), Chantal Csajka, (unknown), Thierry Buclin	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact